[The median survival times for oxaliplatin-treated gastric cancer patients with Arg/Arg or Arg/Gln genotypes of XRCC1 gene were significantly longer than others (P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE